NCT04587609 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Asch DA, Rosin R
Engineering Social Incentives for Health. N Engl J Med. 2016 Dec 29;375(26):2511-3. doi: 10.1056/NEJMp1603978.
Hayashi Y, Russo CT, Wirth O
Texting while driving as impulsive choice: A behavioral economic analysis. Accid Anal Prev. 2015 Oct;83:182-9. doi: 10.1016/j.aap.2015.07.025. Epub 2015 Aug 13.
Kervick AA, Hogan MJ, O'Hora D, Sarma KM
Testing a structural model of young driver willingness to uptake Smartphone Driver Support Systems. Accid Anal Prev. 2015 Oct;83:171-81. doi: 10.1016/j.aap.2015.07.023. Epub 2015 Aug 13.
Klauer SG, Guo F, Simons-Morton BG, Ouimet MC, Lee SE, Dingus TA
Distracted driving and risk of road crashes among novice and experienced drivers. N Engl J Med. 2014 Jan 2;370(1):54-9. doi: 10.1056/NEJMsa1204142.
Loewenstein G, Asch DA, Volpp KG
Behavioral economics holds potential to deliver better results for patients, insurers, and employers. Health Aff (Millwood). 2013 Jul;32(7):1244-50. doi: 10.1377/hlthaff.2012.1163.
Loewenstein G, Brennan T, Volpp KG
Asymmetric paternalism to improve health behaviors. JAMA. 2007 Nov 28;298(20):2415-7.

Comparative Effectiveness of Behavioral Interventions, Safety Devices, and Financial Incentives to Reduce Cellphone Use While Driving Among UBI Policy Holders

Details for clinical trial NCT04587609

Clinical trial NCT04587609 - References